Action by governments and their institutions, health care providers and further stakeholders to inform patients, health care professionals and others about (biosimilar) medicines, including clinical evidence on these medicines and regulatory and policy provisions and guidance as well as to build capacity regarding use of medicines (biosimilars).
Last update: 4 June 2025
Source: PPRI